TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14625517

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (10 g/day for 4 days)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (25 g/day for 4 days)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (35 g/day for 4 days)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 21
Study: 10375051

Group type: EXPERIMENTAL
Intervention: Baseline binge eating status
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Changes in Binge Eating Scale (BES) scores
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Changes in Binge Eating Scale (BES) scores with depression scores included
Number of subjects: 444
Study: 8836747

Group type: EXPERIMENTAL
Intervention: DNR patients in the special care unit
Number of subjects: 220

Group type: COMPARATOR
Intervention: Non-DNR patients
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: DNR patients
Number of subjects: 220
Study: 1892004

Group type: EXPERIMENTAL
Intervention: Cefpirome 0.5 g b.i.d. (1 g group)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Cefpirome 1.0 g b.i.d. (2 g group)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Ceftazidime 1.0 g b.i.d. (CAZ group)
Number of subjects: 530
Study: 6436732

Group type: EXPERIMENTAL
Intervention: Carbohydrate intake (rapidly or slowly absorbed sugars, given by mouth or IV injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium valproate
Number of subjects: 0
Study: 30371759

Group type: EXPERIMENTAL
Intervention: Home Blood Pressure Monitoring (HBPM)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 213
Study: 29846606

Group type: EXPERIMENTAL
Intervention: Sila-Mix (MIX)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Sila-Max (MAX)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 2
Study: 27006655

Group type: EXPERIMENTAL
Intervention: 2800 IU vitamin D3 daily for eight weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Matching placebo for eight weeks
Number of subjects: 200
Study: 24809432

Group type: EXPERIMENTAL
Intervention: Expiratory ribcage compression (ERCC) before endotracheal suctioning
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (no ERCC before endotracheal suctioning)
Number of subjects: 70
Study: 22853731

Group type: EXPERIMENTAL
Intervention: Low number of symptoms (0-12 symptoms)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: High number of symptoms (13-32 symptoms)
Number of subjects: 110
Study: 20528599

Group type: EXPERIMENTAL
Intervention: Long-acting beta-agonists (LABAs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Case-control methodology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 0
Study: 17609661

Group type: EXPERIMENTAL
Intervention: Baseline HRQOL scores (EORTC QLQ‐C30 and BN 20)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Classical analysis
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Refined analyses (bootstrap re‐sampling, C‐indexes, R(2)‐coefficients)
Number of subjects: 490
Study: 18623040

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI (various strengths)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI (steady state)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI (repeated dose)
Number of subjects: 28
Study: 14870994

Group type: EXPERIMENTAL
Intervention: Statewide home-visiting program to prevent child abuse
Number of subjects: 643
Study: 11380135

Group type: EXPERIMENTAL
Intervention: Medoff sliding plate (MSP)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Compression hip screw (CHS)
Number of subjects: 114
Study: 9423749

Group type: EXPERIMENTAL
Intervention: Methotrexate 50 mg/m2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methotrexate 60 mg/m2
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methotrexate 50 mg/m2 and 60 mg/m2
Number of subjects: 20
Study: 8255928

Group type: EXPERIMENTAL
Intervention: Topical 2% escin gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3307307

Group type: EXPERIMENTAL
Intervention: Calcium supplementation 2,000 mg daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 28
Study: 31794102

Group type: EXPERIMENTAL
Intervention: Intraoral Er: YAG laser (SMOOTH mode)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Extraoral approach
Number of subjects: 20
Study: 31152567

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) using toluidine blue (10 mg/mL; 3 min) and a 635-nm laser (750 mW; 10 s/implant side; minimum of 60 mW/cm2)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 131
Study: 27029960

Group type: EXPERIMENTAL
Intervention: Low intensity isometric handgrip exercise (4×2 minutes sustained contractions at 30% of maximal volitional contraction interspersed with 1‐minute rest intervals)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (rest for 15 minutes)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low intensity isometric handgrip exercise
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study: 25564396

Group type: EXPERIMENTAL
Intervention: Handheld echocardiography (HAND)
Number of subjects: 4773

Group type: COMPARATOR
Intervention: Standard portable echocardiography (STAND)
Number of subjects: 4773
Study: 23336469

Group type: EXPERIMENTAL
Intervention: Behavioural intervention (single nurse consultation and self-help manual)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study: 22295386

Group type: COMPARATOR
Intervention: Percutaneous Needle Aspiration (PNA)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Percutaneous Catheter Drainage (PCD)
Number of subjects: 82
Study: 19408467

Group type: EXPERIMENTAL
Intervention: Weighted implement training
Number of subjects: 48
Study: 17343009

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scientific evaluation of clinical efficacy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protocol design for TCM clinical therapeutic research
Number of subjects: 0
Study: 14976601

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (DF)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study: 11996212

Group type: EXPERIMENTAL
Intervention: Metadate CD (20 mg capsule)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Concerta (18 mg tablet)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 x 20 mg capsules
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3 x 20 mg capsules
Number of subjects: 60
Study: 9476972

Group type: EXPERIMENTAL
Intervention: Oral delta9-tetrahydrocannabinol (delta9-THC) 7.5 mg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Oral delta9-tetrahydrocannabinol (delta9-THC) 15 mg
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 7666121

Group type: EXPERIMENTAL
Intervention: Pefloxacin 800 mg i.v. every 24 hours
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Pefloxacin 800 mg per os every 24 hours
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 500 mg per os every 12 hours
Number of subjects: 90
Study: 2698804

Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate (MPSS) 125 mg/day intravenous for 8 weeks
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study: 4910188

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 31163279

Group type: EXPERIMENTAL
Intervention: Experimental arm
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 161
Study: 28100606

Group type: EXPERIMENTAL
Intervention: Predictive Hyperglycemia and Hypoglycemia Minimization (PHHM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Predictive Low-Glucose Insulin Suspension (PLGS)
Number of subjects: 30
Study: 25739904

Group type: EXPERIMENTAL
Intervention: 2 mg intraventricular TPA every 12 h (five doses)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo every 12 h (five doses)
Number of subjects: 12
Study: 24517060

Group type: EXPERIMENTAL
Intervention: Yishen Qingli Granule (YQG) combined with low-dose Tripterygium Wilfordii multiglycoside Tablet (TWT)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group (placebo for YQG and TWT)
Number of subjects: 231
Study: 21946446

Group type: EXPERIMENTAL
Intervention: Teuffel‐Mignon (TF) device
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Coxa‐Flex (CF) device
Number of subjects: 118
Study: 19683095

Group type: EXPERIMENTAL
Intervention: WRITE Symptoms (a Written Representational Intervention To Ease Symptoms), a web‐based, symptom management intervention for women with recurrent ovarian cancer.
Number of subjects: 0
Study: 16963658

Group type: EXPERIMENTAL
Intervention: FSC 250/50
Number of subjects: 185
Study: 16280561

Group type: EXPERIMENTAL
Intervention: Presence of depressive symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlling for prior history of depression, increased life stress, and current psychoactive medication
Number of subjects: 0
Study: 11573100

Group type: EXPERIMENTAL
Intervention: Bismuth subcitrate 120 mg plus metronidazole 250 mg plus tetracycline 250 mg qid plus omeprazole 20 mg bid for 7 days (OBMT)
Number of subjects: 161
Study: 9400034

Group type: EXPERIMENTAL
Intervention: Amiodarone (600 mg/day for 7 days, then 200 mg/day until discharge)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 124
Study: 7960359

Group type: EXPERIMENTAL
Intervention: Levamisole alone
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Levamisole + topical 0.1% fluocinolone acetonide
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Levamisole + topical 0.05% clobetasol propionate
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 64
Study: 3654034

Group type: EXPERIMENTAL
Intervention: Cimetropium bromide 50 mg, p.o. 3 times per day for 1 week
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (exact dosage not specified)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31724349

Group type: EXPERIMENTAL
Intervention: Acupuncture at Renying (ST 9) applied once a day, 6 times a week for 4 weeks.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nifedipine (control group treatment).
Number of subjects: 80
Study: 29156299

Group type: EXPERIMENTAL
Intervention: Screening arm (CA-125 and transvaginal ultrasound annually for 3-5 years)
Number of subjects: 78215

Group type: EXPERIMENTAL
Intervention: Screening arm
Number of subjects: 78215

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 78215
Study: 26416334

Group type: EXPERIMENTAL
Intervention: Exercise therapy with booster sessions
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Exercise therapy plus manual therapy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Exercise therapy plus manual therapy with booster sessions
Number of subjects: 75

Group type: COMPARATOR
Intervention: Exercise therapy in consecutive sessions
Number of subjects: 75
Study: 23168337

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy
Number of subjects: 684
Study: 22101876

Group type: EXPERIMENTAL
Intervention: Diet enriched with carp meat (200 g twice weekly for 4 weeks)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard spa diet
Number of subjects: 143
Study: 19747918

Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (90 microg/week) maintenance therapy
Number of subjects: 764

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 764
Study: 17011184

Group type: EXPERIMENTAL
Intervention: Oral capecitabine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nordic bolus FL
Number of subjects: 60
Study: 15122434

Group type: EXPERIMENTAL
Intervention: 1 second response speed
Number of subjects: 69
Study: 11105526

Group type: EXPERIMENTAL
Intervention: Rereading texts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading texts once
Number of subjects: 0
Study: 9631802

Group type: EXPERIMENTAL
Intervention: N-acetyl-L-cysteine (NAC) 150 mg/kg bolus, followed by a continuous infusion of 50 mg/kg over 4 hours (n=12)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: N-acetyl-L-cysteine (NAC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (n=10)
Number of subjects: 22
Study: 7874838

Group type: EXPERIMENTAL
Intervention: Recombinant interleukin-2 (18 x 10(6) i.u./day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2963663

Group type: EXPERIMENTAL
Intervention: 35 micrograms ethinyl oestradiol + Cyproterone acetate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 micrograms ethinyl oestradiol + Cyproterone acetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31789060

Group type: EXPERIMENTAL
Intervention: Falls efficacy (Short Falls Efficacy Scale‐International)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Fear of falling (one‐item question)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Low perceived ability to manage falls
Number of subjects: 115
Study: 31366977

Group type: EXPERIMENTAL
Intervention: Methylation-specific PCR (MSP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pyrosequencing (PYR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MSP and PYR in tissue
Number of subjects: 0
Study: 28501537

Group type: EXPERIMENTAL
Intervention: Exercise (3 times/week for 12 weeks)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Exercise and Control
Number of subjects: 27
Study: 25948208

Group type: EXPERIMENTAL
Intervention: Compound Zaofan pill combined with cyclosporine and androgen
Number of subjects: 76

Group type: COMPARATOR
Intervention: Cyclosporine and androgen alone
Number of subjects: 76

Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 76
Study: 23647981

Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 38
Study: 21257829

Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 60
Study: 18061593

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening for aneuploidy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no prescreening)
Number of subjects: 0
Study: 17069814

Group type: EXPERIMENTAL
Intervention: C11994T mutation in the ND4 gene
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normozoospermic fertile men
Number of subjects: 34
Study: 12620132

Group type: EXPERIMENTAL
Intervention: Centrally acting antihypertensive drugs and beta‐adrenergic blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Digitalis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium‐channel blocker verapamil
Number of subjects: 0
Study: 14505192

Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 0
Study: 10759055

Group type: EXPERIMENTAL
Intervention: Theoretical orientation towards attachment
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Self-report measure of theoretical orientation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Availability bias due to suggestion in referral letter
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Theoretical orientation
Number of subjects: 64
Study: 8648358

Group type: EXPERIMENTAL
Intervention: HFX RT with 1.2 Gy twice daily to a total dose of 69.6 Gy (n = 66)
Number of subjects: 131

Group type: COMPARATOR
Intervention: HFX RT with CHT consisting of 50 mg of carboplatin and 50 mg of etoposide given on each RT day (n = 65)
Number of subjects: 131
Study: 1626664

Group type: EXPERIMENTAL
Intervention: Subarachnoid hyperbaric bupivacaine 15 mg with 50 micrograms of fentanyl (group A)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Subarachnoid hyperbaric bupivacaine 15 mg with 25 micrograms of fentanyl (group B)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Subarachnoid hyperbaric bupivacaine 15 mg with 12.5 micrograms of fentanyl (group C)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 1 ml of saline (group D)
Number of subjects: 28
Study: 6375243

Group type: EXPERIMENTAL
Intervention: Irradiation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 25
Study: 2437837

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (intravenous)
Number of subjects: 9
Study: 30659901

Group type: EXPERIMENTAL
Intervention: Off-clamp robot-assisted partial nephrectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: On-clamp robot-assisted partial nephrectomy
Number of subjects: 80
Study: 28382618

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.6 mg/m2 intravenously on days 1, 8, 15, and 22 for four 35-day cycles
Number of subjects: 104

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 104
Study: 26437422

Group type: EXPERIMENTAL
Intervention: ProfScreen intervention (screening program)
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Emergency procedure for suicidal students
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Qualitative analysis of clinician’s motivations
Number of subjects: 1007
Study: 23647281

Group type: EXPERIMENTAL
Intervention: Acceptance-based behavior therapy (ABBT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Applied relaxation (AR)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both treatments (ABBT and AR)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 81
Study: 20809177

Group type: EXPERIMENTAL
Intervention: Distal gastrectomy
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Pylorus-preserving gastrectomy
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Resumed activities
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Reduced activities
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Minimal activities
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Did not resume activities due to poor physical condition
Number of subjects: 211
Study: 19274056

Group type: EXPERIMENTAL
Intervention: Diet and exercise
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Diet, exercise and acupuncture
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Changes in lean body mass
Number of subjects: 27
Study: 16482646

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg administered twice weekly
Number of subjects: 77

Group type: COMPARATOR
Intervention: Etanercept 25 mg administered twice weekly
Number of subjects: 77
Study: 15262358

Group type: EXPERIMENTAL
Intervention: Fluid hystroscopy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 11382520

Group type: EXPERIMENTAL
Intervention: Simulated EMS transport stress (n = 16)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 32
Study: 9404860

Group type: EXPERIMENTAL
Intervention: Hyperoxia (F(I)O2 0.622)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Normoxia (F(I)O2 0.209)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hypoxia (F(I)O2 0.158)
Number of subjects: 6
Study: 8127928

Group type: EXPERIMENTAL
Intervention: Moclobemide (81 patients, 100-300 mg/day)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Tranylcypromine (79 patients, 10-30 mg/day)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 160

Group type: COMPARATOR
Intervention: Tranylcypromine
Number of subjects: 160
Study: 3038552

Group type: EXPERIMENTAL
Intervention: Blood from donors without detectable CMV antibodies (CMV seronegative blood)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Blood from unselected donors
Number of subjects: 34
Study: 29202885

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 197
Study: 28587620

Group type: EXPERIMENTAL
Intervention: Buprenorphine (8 mg per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methadone (40 mg per day)
Number of subjects: 40
Study: 26223309

Group type: EXPERIMENTAL
Intervention: Telecoaching plus portion control plate
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study: 23017529

Group type: EXPERIMENTAL
Intervention: Robotic assisted laparoscopic radical cystectomy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Open radical cystectomy
Number of subjects: 47
Study: 21169634

Group type: EXPERIMENTAL
Intervention: Acupuncture at pericardium 6 bilaterally, depth of approximately 0.7 cm, median duration of 21 min during anaesthesia, followed by acupressure wristbands for 24 h and standard treatment.
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 154
Study: 18268152

Group type: EXPERIMENTAL
Intervention: Levosimendan (0.1 and 0.2 microg x kg(‐1) x min(‐1))
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 16948927

Group type: EXPERIMENTAL
Intervention: Risperidone (1 mg/day for 6 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 14503797

Group type: EXPERIMENTAL
Intervention: Leuprorelin (11.25 mg s.c. every 3 months for 2 years)
Number of subjects: 133

Group type: COMPARATOR
Intervention: CMF chemotherapy (6 cycles)
Number of subjects: 133
Study: 11154141

Group type: EXPERIMENTAL
Intervention: 2 mg estradiol plus 1 mg norethisterone acetate, 1 tablet daily (HRT group)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 140